Keyuan Pharmaceutical shines at the 92nd China International Pharmaceutical Raw Materials Exhibition, leveraging a global perspective to power ahead on its international journey!
Publish Time:
2025-05-21
On the 21st, the 92nd China International Pharmaceutical Raw Materials/Materials/Packaging/Equipment Fair (API China) kicked off with great fanfare at the China Import and Export Fair Complex in Guangzhou, bringing together pharmaceutical companies from around the globe in the "Flower City." As a leading enterprise in China's specialized chemical raw materials sector, Keyuan Pharmaceutical (stock code: 3012851.SZ) was invited to showcase its range of core products and groundbreaking technological advancements, highlighting its robust capabilities in raw material R&D, manufacturing, and global expansion. The company’s presence drew extensive attention from industry experts, strategic partners, and media representatives alike.
On the 21st, the 92nd China International Pharmaceutical Raw Materials/Middle Intermediates/Packaging Materials/Equipment Trade Fair (API China) kicked off grandly at the China Import and Export Fair Complex in Guangzhou, bringing together pharmaceutical companies from around the globe in the "Flower City." As a leading enterprise in China's specialized chemical raw materials sector, Keyuan Pharmaceutical (stock code: 3012851.SZ) was invited to showcase its multiple core products and groundbreaking technological advancements, highlighting its robust capabilities in raw material R&D, manufacturing, and global expansion—drawing significant attention from industry experts, partners, and media alike.

At Booth 10.3E18, the cutting-edge, tech-savvy, and modern spatial design immediately catches the eye. A range of core pharmaceutical products—each meeting international standards—is proudly showcased at the booth, spanning multiple therapeutic areas. These products have successively earned prestigious international certifications, including those from the U.S. FDA, the EU CEP, and South Korea’s MFDS. Their exceptional quality and reliable performance have already established a strong reputation in global markets.
Through a variety of formats—including illustrated presentations, physical product displays, and multimedia demonstrations—Keyuan Pharmaceutical comprehensively showcased the company’s international standards and strong capabilities in areas such as API research and development, manufacturing, and quality control.

Gao Chunpo, Chairman and President of the company, led the marketing team in engaging in in-depth discussions with customers from around the world. During these conversations, he provided a detailed overview of Keyuan Pharmaceutical's R&D innovation capabilities, product portfolio, scalable production advantages, and its robust quality management system—clearly conveying the company's unwavering commitment and confidence in cultivating both domestic and international markets. Thanks to its exceptional product quality and sincere collaborative approach, Keyuan Pharmaceutical established strong relationships and mutual trust with numerous domestic and international partners at the exhibition, solidifying the foundation for future cooperation and opening up broader opportunities for market expansion.

API China is a vital platform connecting the global pharmaceutical industry chain. This year's exhibition fully showcased Keyuan Pharmaceutical's strong capabilities, while also opening up broader avenues for international collaboration for the company. Moving forward, the company will continue to ramp up R&D investments, deepen partnerships with leading domestic and international research institutions, and steadfastly embrace its development philosophy of "product-centricity, long-termism, and altruism." Guided by international standards, Keyuan Pharmaceutical is steadily advancing toward its vision of becoming a diversified, symbiotic biopharmaceutical enterprise.
Latest News